Post-Radiotherapy Eye Monitoring: Why It Matters & Managing Complications – Mr. Guy Negretti

28:11
Updates from the Ocular Melanoma UK Team: Jo Gumbs, Matt Selby & Alex Harman

20:04
Conjunctival Melanoma and its Precursor Lesions - Dr Yamini Krishna

26:35
Do people change their lifestyle after a diagnosis of uveal melanoma?

29:44
Building the Digital Database & Advancing Uveal Melanoma Research - Dr. Helen Kalirai

30:32
An update on clinical trials for uveal melanoma in the UK - Dr Heather Shaw

28:14
Why Me and other popular questions - Dr Hibba Quhill

12:09
Welcome Message from Ocular Melanoma UK CEO - Jo Gumbs

36:59